Vasily Studitsky, PhD, Joins Fox Chase Cancer Center as a Professor in the Cancer Epigenetics Program
PHILADELPHIA, PA (August 9, 2013)—Vasily Studitsky, PhD, has joined Fox Chase Cancer Center as a Professor in the Cancer Epigenetics Program. He comes to Fox Chase from Wayne State University and the University of Medicine and Dentistry of New Jersey, where he was a full Professor. Dr. Studitsky’s research looks at molecular mechanisms and regulation of eukaryotic transcription, and the factors involved in cancer development and human aging.
Dr. Studitsky received his PhD from the W. Engelhardt Institute of Molecular Biology in Moscow, Russia. He did his postdoctoral fellowship at the National Institutes of Health, where he conducted research on transcription through chromatin by model bacteriophage SP6 RNA polymerase and yeast RNA polymerase III.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).